Frans Claas, Ph.D, is director of the Eurotransplant Reference Laboratory and professor “Immunogenetics of transplantation” at the Leiden University Medical Center in Leiden, the Netherlands. The main topics of his current research are the differential immunogenicity of HLA mismatches in clinical transplantation and the immunology of pregnancy as a model for transplantation tolerance. The studies of his research group have generated more than 500 papers in peer-reviewed journals. He was the initiator of a special program within Eurotransplant to enhance transplantation of highly sensitized renal transplant patients on basis of acceptable HLA mismatches. He is an active member of different professional societies as reflected amongst others by his past-presidency of the European Federation for Immunogenetics (EFI) and past-membership of the Board of the American Society for Histocompatibilty and Immunogenetics (ASHI). He is an editor-in chief of Transplant Immunology.
14:15 - 15:45
|State-of-the-Art Session — Strategies for the Sensitized Patient||The Role of the Acceptable Mismatch Strategy for Sensitized Patients||TBD|
13:15 - 14:15
|Lunch and Learn — Lunch and Learn 2||Toward HLA Epitope Matching in Clinical Transplantation||TBD|